Boeing (BA) Offering Possible 56.25% Return Over the Next 24 Calendar Days

Boeing's most recent trend suggests a bullish bias. One trading opportunity on Boeing is a Bull Put Spread using a strike $367.50 short put and a strike $362.50 long put offers a potential 56.25% return on risk over the next 24 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $367.50 by expiration. The full premium credit of $1.80 would be kept by the premium seller. The risk of $3.20 would be incurred if the stock dropped below the $362.50 long put strike price.

The 5-day moving average is moving down which suggests that the short-term momentum for Boeing is bearish and the probability of a decline in share price is higher if the stock starts trending.

The 20-day moving average is moving up which suggests that the medium-term momentum for Boeing is bullish.

The RSI indicator is at 64.83 level which suggests that the stock is neither overbought nor oversold at this time.

To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here

LATEST NEWS for Boeing

Jet industry's grand masters fight to a draw in Dubai
Sat, 23 Nov 2019 14:22:29 +0000
After insisting for 15 years that the superjumbo is the future, Emirates airline has been forced by the demise of the A380 to embrace smaller wide-body jets, resulting in a flurry of manoeuvres between planemakers at this week's Dubai Airshow. The 555-seat A380 is near the end of production, setting off a series of interlocking deals as top buyer Emirates reviews its fleet against the backdrop of fragmenting travel demand. Delays in the 406-seat Boeing 777X also weighed in the shake-up.

UPDATE 1-Canadian official's critique of 737 MAX software reflects 'working-level' view – regulator
Fri, 22 Nov 2019 23:26:53 +0000
MONTREAL/WASHINGTON, Nov 22 (Reuters) – An email sent by a Transport Canada official urging Boeing to remove an anti-stall system involved in two 737 MAX crashes reflects “working-level discussions” and were not reviewed by the Canadian regulator, the agency said on Friday. The email was sent to the Federal Aviation Administration (FAA), the European Union Aviation Safety Agency (EASA) and Brazil’s National Civil Aviation Agency, the New York Times said.

Canadian official's critique of 737 MAX software reflects 'working-level' view: regulator
Fri, 22 Nov 2019 22:20:00 +0000
MONTREAL/WASHINGTON (Reuters) – An email sent by a Transport Canada official urging Boeing to remove an anti-stall system involved in two 737 MAX crashes reflects “working-level discussions” and were not reviewed by the Canadian regulator, the agency said on Friday. The email was sent to the Federal Aviation Administration (FAA), the European Union Aviation Safety Agency (EASA) and Brazil’s National Civil Aviation Agency, the New York Times said.

US Indexes Higher Friday, but Down for the Week
Fri, 22 Nov 2019 22:09:30 +0000
S&P; 500 up 23.91% for the year Continue reading…

Dow Jones Today: Trade Progress Pushes Stocks, Healthcare Helps Dow
Fri, 22 Nov 2019 21:31:54 +0000
Markets got some trade relief to close the week as the three major benchmarks climbed higher following comments from President Trump that the U.S. and China are inching closer to signing Phase I of a trade deal.Source: Provided by Finviz * The S&P 500 rallied 0.22% * The Dow Jones Industrial Average jumped 0.39% * The Nasdaq Composite added 0.16% * Pfizer (NYSE:PFE) surged 1.56%, leading healthcare stocks as the group pushed the Dow Jones to the upside to close the weekTrump, as he often does, said China wants and needs the trade deal more than the U.S., indicating that's the impetus for reaching terms on the first part of the accord."Chinese Vice Premier Liu He has invited Robert Lighthizer to Beijing for further talks later this month, according to people familiar with the matter, and Washington will likely postpone new tariffs scheduled for December even if there's no deal by then, the South China Morning Post reported," according to Bloomberg.InvestorPlace – Stock Market News, Stock Advice & Trading TipsThe president's comments may or may not qualify as clarity, but in a week in which trade loomed larger than many investors would have preferred, it was good to go out on a strong note thanks to positive trade musings. * 10 Tech Stocks to Buy Now for 2025 In late trading, 22, or more than two-thirds, of the Dow's 30 components were trading higher with each of the index's healthcare components in the green. Pfizer PowerPfizer was the best-performing member of the Dow today, a welcome respite for one of the index's worst-performing names in 2019. A positive article in Barron's did the trick for Pfizer shares today.The article notes that investors may not be appreciating Pfizer's efforts to shed its consumer products unit and merge its off-patent business, Upjohn, with Mylan (NYSE:MYL). As a result, the stock is attractive relative to some blue-chip pharmaceuticals rivals, including fellow Dow component Merck (NYSE:MRK)."Pfizer is clearly set to be a different sort of investment than it was before the spinoff," reports Barron's. "The company is splitting the dividend proportionally between Pfizer and the generic-drug spinoff, and executives have said they expect that dividend increases, which have been steady in recent years, will slow in the near term. Can Pfizer go from being an income play to a growth story?" Healthcare Part 2Pfizer wasn't the only Dow healthcare stock trading higher today. The sector, a laggard for much of this year, has recently been building some momentum. Johnson & Johnson (NYSE:JNJ) gained more than 1% today, while MRK failed to climb higher with some market observers citing ebbing political pressure on the group as the fuel for a late-year healthcare rally.That assessment has some validity."Healthcare stocks rallied sharply on Friday after U.S. Senator Elizabeth Warren, one of the top Democratic presidential contenders and a Medicare for All proponent, revealed how she would implement her healthcare plan," reports Reuters. "It included a timeline that would initially retain many aspects of the current system, including employer-based private insurance, while transitioning Americans to the government health plan that currently primarily covers individuals 65 and older." More BoeingBoeing (NYSE:BA) is back thanks to gain of 1.3%, putting it in the upper tier of Dow stocks today.This might be surprising because the Dow's largest constituent may have to push back the January timeline for getting the 737 MAX passenger back in the skies.A report in Gulf News suggests the U.S. Federal Aviation Administration (FAA) isn't committing to January and that the end of the first quarter is a more reasonable expectation. * 7 Top Stocks to Buy for 2020 When Sorry Doesn't Cut ItIntel (NASDAQ:INTC) lost about 1% today, making it the Dow's worst performer. Earlier this week, the company had to apologize to customers for PC chip shortages. Headlines like that are, of course, bad for the company behind them, but it can lead to upside for rivals, particularly in the intensely competitive semiconductor space. Bottom Line on the Dow Jones TodayWith earnings season in the books for Dow components, some material I located today may prove interesting/instructive as it pertains directly to the 30 Dow stocks. It's about earnings reporting, as in GAAP vs. non-GAAP with the former generally being preferred by analysts but both being used by some companies."For Q3 2019, 20 (67%) of the 30 companies in the DJIA reported non-GAAP EPS in addition to GAAP EPS for the third quarter," according to FactSet research. "Since 2016, 73% of companies in the DJIA have reported non-GAAP EPS in addition to GAAP EPS on average. Of these 20 companies, 14 (70%) reported non-GAAP EPS that exceeded GAAP EPS."As of this writing, Todd Shriber did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Companies Using Artificial Intelligence to Outperform the Market * 7 Earnings Reports to Watch Next Week * 6 Retail Stocks Dropping Hard Ahead of Black Friday The post Dow Jones Today: Trade Progress Pushes Stocks, Healthcare Helps Dow appeared first on InvestorPlace.

Related Posts

 

MarketTamer is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of MarketTamer are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.


This company makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.


The content on any of MarketTamer websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The www.MarketTamer.com educational training program and software services are provided to improve financial understanding.


The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.